Insulet (PODD) Divestments (2016)

Insulet's (PODD) quarterly Divestments came in at $1.1 million in Q2 2016, down 76.16% on a QoQ basis from $4.6 million in Q1 2016.

Insulet (PODD) Divestments (2016) Analysis & Trends

Insulet (PODD) has 1 years of Divestments data on file, last reported at $1.1 million in Q2 2016.

Quarterly Divestments changed N/A year-over-year to $1.1 million in Q2 2016, while the trailing twelve-month figure through Mar 2017 was $1.1 million (down 76.16% YoY) and the FY2016 annual result came in at $5.7 million, changed N/A from the prior year.
Divestments slipped to $1.1 million in Q2 2016, from $4.6 million in the prior quarter.
In the past five years, Divestments ranged from a high of $4.6 million in Q1 2016 to a low of $1.1 million in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	-
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	-
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	-
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	-
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	-
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	-
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	153.43 Mn
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	-
10	Insulet	10.37 Bn	9.84 Bn	562.60 Mn	-

Download Data

Date	Value
Jun 30, 2016	1.10 Mn
Mar 31, 2016	4.61 Mn